These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6459990)

  • 21. Effect of trypsinization on the activity of human factor H.
    Hong K; Kinoshita T; Dohi Y; Inoue K
    J Immunol; 1982 Aug; 129(2):647-52. PubMed ID: 6211491
    [No Abstract]   [Full Text] [Related]  

  • 22. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
    Koistinen V; Wessberg S; Leikola J
    Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively coexpressed on a series of B-cell lines and their derived somatic cell hybrids.
    Jønsson V; Wells A; Klein G
    Cell Immunol; 1982 Sep; 72(2):263-76. PubMed ID: 6983911
    [No Abstract]   [Full Text] [Related]  

  • 24. A spatial association between membrane IgD and the receptor for C3b (CR1) at the cell surface of murine B lymphocytes.
    Sitia R; Rabellino EM; Sockell M; Hämmerling U
    J Immunol; 1981 Jan; 126(1):107-12. PubMed ID: 7005331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
    Mold C; Kingzette M; Gewurz H
    J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzymic assay of C3b receptor on intact cells and solubilized cells.
    Sim E; Sim RB
    Biochem J; 1983 Feb; 210(2):567-76. PubMed ID: 6222733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation by adherent cells of macromolecular synthesis in lymphocyte populations.
    Gillette RW
    Cell Immunol; 1977 Oct; 33(2):309-21. PubMed ID: 303148
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement-dependent triggering of B-cells, T-cells and macrophages.
    Dierich MP; Erdei A; Gergely J; Myones BL; Schulz TF
    Behring Inst Mitt; 1987 Jun; (81):128-32. PubMed ID: 2957999
    [No Abstract]   [Full Text] [Related]  

  • 31. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK
    J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The separation of functionally distinct forms of the third component of human complement (C3).
    Parkes C; DiScipio RG; Kerr MA; Prohaska R
    Biochem J; 1981 Mar; 193(3):963-70. PubMed ID: 6458280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Oct; 131(4):1930-5. PubMed ID: 6225800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
    Joiner K; Sher A; Gaither T; Hammer C
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferation.
    Erdei A; Spaeth E; Alsenz J; Rüde E; Schulz T; Gergely J; Dierich MP
    Mol Immunol; 1984 Dec; 21(12):1215-21. PubMed ID: 6240596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An improved micro-method for enumeration of human B-cell rosettes with mouse red blood cells.
    Dolen JG; Park BH
    Immunol Commun; 1978; 7(6):677-80. PubMed ID: 311332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the alternative complement pathway.
    Fearon DT
    CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
    [No Abstract]   [Full Text] [Related]  

  • 38. Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM.
    Carter RH; Fearon DT
    J Immunol; 1989 Sep; 143(6):1755-60. PubMed ID: 2528579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.
    Lambris JD; Avila D; Becherer JD; Müller-Eberhard HJ
    J Biol Chem; 1988 Aug; 263(24):12147-50. PubMed ID: 2969896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of complement-protein-C3b density on the binding of complement factor H to surface-bound C3b.
    Koistinen V
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):255-9. PubMed ID: 1835839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.